NARCOLEPSY TYPE 1
Clinical trials for NARCOLEPSY TYPE 1 explained in plain language.
Never miss a new study
Get alerted when new NARCOLEPSY TYPE 1 trials appear
Sign up with your email to follow new studies for NARCOLEPSY TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a headband replace the sleep lab? new study tests At-Home narcolepsy diagnosis
Diagnosis CompletedThis study tested a headband called Dreem 3S that people wear at home to monitor sleep and wake patterns. The goal was to see if it can help diagnose narcolepsy, a condition that causes extreme daytime sleepiness. 78 adults took part, and researchers checked how well the device w…
Matched conditions: NARCOLEPSY TYPE 1
Sponsor: Beacon Biosignals • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Dream control: a new behavioral approach to tame narcolepsy nightmares
Symptom relief CompletedThis study tests two behavioral therapies—imagery rehearsal therapy (IRT) and targeted dream control (TDC)—to reduce nightmares in adults with narcolepsy. Participants attend therapy sessions, keep a daily sleep log, and complete questionnaires. Some Chicago-area participants als…
Matched conditions: NARCOLEPSY TYPE 1
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jul 01, 2026 23:00 UTC
-
New narcolepsy drug shows promise in reducing sudden sleep attacks and muscle collapse
Symptom relief CompletedThis study tested a new medicine called ALKS 2680 in 92 adults with narcolepsy type 1, a condition that causes severe daytime sleepiness and sudden muscle weakness (cataplexy). Participants stopped their usual narcolepsy medications and received either ALKS 2680 or a placebo for …
Matched conditions: NARCOLEPSY TYPE 1
Phase: PHASE2 • Sponsor: Alkermes, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Dream control therapy eases night terrors and sleep paralysis in narcolepsy patients
Symptom relief CompletedThis study tested a six-session behavioral therapy that teaches people with narcolepsy type 1 how to become aware during dreams (lucid dreaming) and control frightening images. Ninety-eight adults took part, with half receiving the therapy and half getting standard care. The goal…
Matched conditions: NARCOLEPSY TYPE 1
Phase: NA • Sponsor: Institute of Behavioral Sleep Medicine, Colombia • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
New Slow-Release pill for narcolepsy passes early safety check
Symptom relief CompletedThis early-phase study tested a new slow-release form of pitolisant (HBS-201) in 46 adults with narcolepsy. The goal was to see if starting at a full dose is tolerable. Participants took the drug for 14 days, and researchers tracked side effects and dropouts.
Matched conditions: NARCOLEPSY TYPE 1
Phase: PHASE1 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New pill aims to keep narcolepsy patients awake and steady
Symptom relief CompletedThis study tested an experimental drug called TAK-861 in 105 adults with narcolepsy type 1, a condition causing severe daytime sleepiness and sudden muscle weakness (cataplexy). Participants took either TAK-861 or a placebo daily for 3 months. The main goal was to see if the drug…
Matched conditions: NARCOLEPSY TYPE 1
Phase: PHASE3 • Sponsor: Takeda • Aim: Symptom relief
Last updated Jun 26, 2026 16:58 UTC
-
New website aims to boost social skills for teens with narcolepsy
Knowledge-focused CompletedThis study tested a website designed to help teenagers with narcolepsy or idiopathic hypersomnia and their families understand and improve social relationships. Twenty-five teens and their parents reviewed the website's content, which included animations, patient stories, and exp…
Matched conditions: NARCOLEPSY TYPE 1
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC